Complete Remission of Multiple Pulmonary Metastases of Endometrial Adenocarcinoma Treated with a Mixture of Low Molecular Weight Fucoidan and Canvaria gladiata Extract: A Case Report
Keywords:
Endometrioid adenocarcinoma, Pulmonary metastasis, Docetaxel+Carboplatin (DC) therapy, Hormone therapy, Low molecular weight fucoidan extract (LMF), Canavalia gladiata extract (CG)Abstract
Endometrial cancer (EC) is the most common malignant tumor in post-menopausal women, and the lung is one of the organs to
which endometrial adenocarcinoma metastasizes. Chemotherapy is helpful for various malignancies, but not all are successful. A
71-year-old-Japanese-woman was diagnosed with metastatic lung cancer stage IV of primary endometrial adenocarcinoma. She
received chemotherapy and hormone therapy after a total hysterectomy and pelvic lymphadenectomy. Subsequently, she visited
this clinic for a second opinion as the metastatic lung cancer had repeated remissions and recurrences. Here, the authors report
a case in which complete remission of metastatic lung cancer was achieved by using a product containing low molecular weight
fucoidan extract (LMF) and Canavalia gladiata extract (CG) (LMF-CG) in combination with Medroxyprogesterone acetate (MPA)
hormone therapy.
Downloads
Published
How to Cite
Issue
Section
License
All content published in Cancer Studies and Molecular Medicine (CSMM) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.